Tejas Patil, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    Janssen
    Topic: 
    Advisory Board
    Date added: 
    10/19/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    Mirati
    Topic: 
    Advisory Board
    Date added: 
    10/19/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    Sanofi
    Topic: 
    Advisory Board
    Date added: 
    10/19/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    Astrazeneca
    Topic: 
    Advisory Board
    Date added: 
    10/19/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    Takeda
    Topic: 
    Lecture
    Date added: 
    10/19/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    EMD Soreno
    Topic: 
    Investigator initiated trial
    Date added: 
    10/19/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Janssen
    Topic: 
    Investigator initiated trial
    Date added: 
    10/19/2021
Return to 2022 Seattle Multidisciplinary Thoracic Oncology Conference